PHOENIX (AZFamily) — The U.S. Senate is considering legislation that would cap the cost of insulin at $35 per month for people on private insurance, a measure that has already cleared a health committee with bipartisan support. Congress approved a similar $35 cap for Medicare recipients in 2022. The new legislation would extend that limit to those covered by private insurance plans. Some lawmakers said the bill still needs more work to address technical concerns before it can advance further.